Literature DB >> 26097260

Studies toward the synthesis of cinachyramine. An efficient route to 1,5-diazabicyclo[4.4.0]dec-5-enes.

Olga V Barykina-Tassa1, Barry B Snider1.   

Abstract

Hydrogenation (3 atm) of readily available pyrido[1,2-a]pyrimidines 10, 14, and 17 over 5% Rh/Al2O3 forms 1,5-diazabicyclo[4.4.0]dec-5-enes 9, 15, and 18 in > 95% yield, providing a general route to this little-studied class of compounds. All attempts to form the tetrahydro-1,2,4-triazine moiety of cinachyramine (1) by rearrangement of amidinium dimethylhydrazone 8 using the procedures developed by Kamatori to convert hydrazone 3a to tetrahydro-1,2,4-triazine 4a were unsuccessful.

Entities:  

Keywords:  1,5-diazabicyclo[4.4.0]dec-5-enes; 1,5-hydrogen shifts; hydrazones; hydrogenation; pyrido[1,2-a]pyridimines

Year:  2015        PMID: 26097260      PMCID: PMC4472388          DOI: 10.1016/j.tetlet.2014.12.071

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  5 in total

1.  An efficient synthesis of bicyclic amidines by intramolecular cyclization.

Authors:  Naoya Kumagai; Shigeki Matsunaga; Masakatsu Shibasaki
Journal:  Angew Chem Int Ed Engl       Date:  2004-01-16       Impact factor: 15.336

2.  [Dehydrogenation of N-secondary cyclic aminals and acylaminals].

Authors:  H Möhrle; C M Seidel
Journal:  Arch Pharm (Weinheim)       Date:  1976-06       Impact factor: 3.751

3.  Nonaromatic amidine derivatives as acylation catalysts.

Authors:  Vladimir B Birman; Ximin Li; Zhenfu Han
Journal:  Org Lett       Date:  2007-01-04       Impact factor: 6.005

4.  Pyrido(1,2-a)pyrimidinium salts. I. Synthesis from 2-aminopyridines and interconversion with 2-(2-acylvinylamino)pyridines.

Authors:  J R Sawyer; D G Wibberley
Journal:  J Chem Soc Perkin 1       Date:  1973

5.  Cyclic amidine inhibitors of indolamine N-methyltransferase.

Authors:  J Rokach; P Hamel; N R Hunter; G Reader; C S Rooney; P S Anderson; E J Cragoe; L R Mandel
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.